Skip to main content

Research Repository

Advanced Search

Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain

Simpson, J. E.; Ince, P. G.; Lace, G.; Forster, G.; Shaw, P. J.; Matthews, F.; Savva, G.; Brayne, C.; Wharton, S. B.

Authors

J. E. Simpson

P. G. Ince

G. Lace

G. Forster

P. J. Shaw

G. Savva

C. Brayne

S. B. Wharton



Abstract

Astrocyte pathology occurs in association with Alzheimer's disease (AD) and in brain ageing, but is poorly characterised. We sought to define the detailed cellular pathology of astrocytes, the extent of population variation and the relationship to Alzheimer-type changes in a population-based cohort. Three staining patterns were associated with GFAP and excitatory amino acid transporter 2 (EAAT2): minimal, moderate or extensive immunoreactivity. GFAP and EAAT2 expression were inversely related (p=0.015), with trends to increased expression of GFAP (p=0.019) and decreased expression of EAAT2 (p=ns) with increasing Braak stage. GFAP and EAAT2 correlated incompletely with β-amyloid and tau immunoreactivity. However, gliosis increased with increasing burden of neuritic (p=0.011), but not diffuse (p=ns), plaques. Double-staining revealed distinct subsets of astrocytes; GFAP+EAAT-, GFAP-EAAT+, or GFAP+EAAT+. In contrast to the variation in GFAP and EAAT2, levels of EAAT1 and S100B showed consistent staining patterns. Alzheimer-type pathology only partially explains the variation in gliosis and astrocyte functional markers, suggesting that other factors contribute to the population variance in astrocyte pathology. © 2008 Elsevier Inc.

Citation

Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010). Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiology of Aging, 31(4), 578-590. https://doi.org/10.1016/j.neurobiolaging.2008.05.015

Journal Article Type Article
Publication Date Apr 1, 2010
Deposit Date Dec 8, 2023
Journal Neurobiology of Aging
Print ISSN 0197-4580
Publisher Elsevier
Volume 31
Issue 4
Pages 578-590
DOI https://doi.org/10.1016/j.neurobiolaging.2008.05.015
Public URL https://hull-repository.worktribe.com/output/4455045